Inhibitory effects of SRT1720 on the apoptosis of rabbit chondrocytes by activating SIRT1 via p53/bax and NF-κB/PGC-1α pathways
- 1 June 2016
- journal article
- research article
- Published by Springer Nature in Current Medical Science
- Vol. 36 (3) , 350-355
Abstract
Summary SRT1720, a new discovered drug, was reported to activate silent information regulator 1 (SIRT1) and inhibit the chondrocyte apoptosis. However, the underlying mechanism remains elusive. In the present study, the chondrocytes were extracted from the cartilage tissues of New Zealand white rabbits, cultured in the presence of sodium nitroprusside (SNP) (2.5 mmol/L) and divided into five groups: 1, 5, 10, and 20 μmol/L SRT1720 groups and blank control group (0 μmol/L SRT1720). MTT assay was used to detect the chondrocyte viability and proliferation, and DAPI staining and flow cytometry to measure the chondrocyte apoptosis. The expression levels of SIRT1, p53, NF-κB/p65, Bax, and peroxisome proliferator-activated receptor gamma coactivator 1-α (PGC-1α) were detected by Western blotting and the expression levels of SIRT1, type II collagen, and aggrecan mRNA by RT-PCR. The results showed that in the SRT1720-treated groups, the nuclei of chondrocytes were morphologically intact and had uniform chromatin. In the blank control group, nuclear rupture into debris was observed in chondrocytes. With the SRT1720 concentration increasing, the chondrocyte viability increased, the apoptosis rate decreased, the protein expression levels of SIRT1 and PGC-1α and the mRNA expression levels of type II collagen and aggrecan increased ({ptP}P<0.05). It was suggested that SRT1720 inhibits chondrocyte apoptosis by activating the expression of SIRT1 via p53/bax and NF-κB/PGC-1α pathways.Keywords
This publication has 24 references indexed in Scilit:
- Stabilization and translocation of p53 to mitochondria is linked to Bax translocation to mitochondria in simvastatin-induced apoptosisBiochemical and Biophysical Research Communications, 2010
- Role of p53 in the anti-proliferative effects of Sirt1 inhibition in prostate cancer cellsCell Cycle, 2009
- Cartilage in normal and osteoarthritis conditionsBest Practice & Research Clinical Rheumatology, 2008
- Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetesNature, 2007
- Regulation of Type II Collagen Expression by Histone Deacetylase in Articular ChondrocytesJournal of Biological Chemistry, 2007
- Effect of resveratrol in experimental osteoarthritis in rabbitsInflammation Research, 2005
- Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylaseThe EMBO Journal, 2004
- Calorie restriction extends Saccharomyces cerevisiae lifespan by increasing respirationNature, 2002
- Negative Control of p53 by Sir2α Promotes Cell Survival under StressCell, 2001
- Characterization of Five Human cDNAs with Homology to the Yeast SIR2 Gene: Sir2-like Proteins (Sirtuins) Metabolize NAD and May Have Protein ADP-Ribosyltransferase ActivityBiochemical and Biophysical Research Communications, 1999